| Product Code: ETC9958279 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) mRNA Synthesis Raw Materials Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) mRNA Synthesis Raw Materials Market - Industry Life Cycle |
3.4 United Kingdom (UK) mRNA Synthesis Raw Materials Market - Porter's Five Forces |
3.5 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United Kingdom (UK) mRNA Synthesis Raw Materials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for mRNA-based therapies and vaccines |
4.2.2 Technological advancements in mRNA synthesis processes |
4.2.3 Growing investments in research and development in the life sciences sector |
4.3 Market Restraints |
4.3.1 High costs associated with raw materials for mRNA synthesis |
4.3.2 Regulatory challenges and complexities in the approval process for mRNA-based products |
4.3.3 Limited availability of skilled professionals in mRNA synthesis |
5 United Kingdom (UK) mRNA Synthesis Raw Materials Market Trends |
6 United Kingdom (UK) mRNA Synthesis Raw Materials Market, By Types |
6.1 United Kingdom (UK) mRNA Synthesis Raw Materials Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Capping Agents, 2021- 2031F |
6.1.4 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Nucleotides, 2021- 2031F |
6.1.5 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Plasmid DNA, 2021- 2031F |
6.1.6 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Enzymes, 2021- 2031F |
6.1.7 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Polymerase, 2021- 2031F |
6.1.8 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By RNase Inhibitor, 2021- 2031F |
6.1.9 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Vaccine Production, 2021- 2031F |
6.2.3 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Therapeutics Production, 2021- 2031F |
6.2.4 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) mRNA Synthesis Raw Materials Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Bipharmaceutical & Pharmaceutical Companies, 2021- 2031F |
6.3.3 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By CROs & CMOs, 2021- 2031F |
6.3.4 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
7 United Kingdom (UK) mRNA Synthesis Raw Materials Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) mRNA Synthesis Raw Materials Market Export to Major Countries |
7.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market Imports from Major Countries |
8 United Kingdom (UK) mRNA Synthesis Raw Materials Market Key Performance Indicators |
8.1 Number of new mRNA-based therapies and vaccines entering clinical trials |
8.2 Research and development expenditure by pharmaceutical and biotech companies in mRNA technologies |
8.3 Number of collaborations and partnerships in the mRNA synthesis raw materials market |
8.4 Adoption rate of mRNA synthesis technologies in the UK life sciences industry |
9 United Kingdom (UK) mRNA Synthesis Raw Materials Market - Opportunity Assessment |
9.1 United Kingdom (UK) mRNA Synthesis Raw Materials Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) mRNA Synthesis Raw Materials Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United Kingdom (UK) mRNA Synthesis Raw Materials Market - Competitive Landscape |
10.1 United Kingdom (UK) mRNA Synthesis Raw Materials Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) mRNA Synthesis Raw Materials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here